Overview

Pioglitazone in Impaired Glucose Tolerance

Status:
Withdrawn
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
In patients with impaired glucose tolerance (IGT), the researchers want to study the relative effects of pioglitazone, simvastatin, or the combination of both on: - intima media thickness (IMT) as an easily assessed marker of atherosclerosis - heart rate variability (HRV) as a marker of autonomic neuropathy - flow-mediated vasodilatation (FMD) of the brachial artery as a marker of endothelial function - vascular and metabolic lab parameters
Phase:
Phase 4
Details
Lead Sponsor:
University of Leipzig
Collaborator:
Institut für Gesundheits- und Praxismanagement GmbH
Treatments:
Pioglitazone
Simvastatin